Nanoparticles and mesenchymal stem cells: a win-win alliance for anticancer drug delivery

about

Nanoparticles and mesenchymal stem cells: a win-win alliance for anticancer drug delivery

Item

http://www.wikidata.org/entity/Q57377122

description

im Jahr 2016 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2016

@uk

name

Nanoparticles and mesenchymal stem cells: a win-win alliance for anticancer drug delivery

@en

Nanoparticles and mesenchymal stem cells: a win-win alliance for anticancer drug delivery

@nl

type

Item

label

Nanoparticles and mesenchymal stem cells: a win-win alliance for anticancer drug delivery

@en

Nanoparticles and mesenchymal stem cells: a win-win alliance for anticancer drug delivery

@nl

prefLabel

Nanoparticles and mesenchymal stem cells: a win-win alliance for anticancer drug delivery

@en

Nanoparticles and mesenchymal stem cells: a win-win alliance for anticancer drug delivery

@nl

P1476

Nanoparticles and mesenchymal stem cells: a win-win alliance for anticancer drug delivery

@en

P2093

Cheng Wang

http://www.w3.org/2001/XMLSchema#string

Fangrong Zhang

http://www.w3.org/2001/XMLSchema#string

Jianping Zhou

http://www.w3.org/2001/XMLSchema#string

Kerong Chen

http://www.w3.org/2001/XMLSchema#string

Min Li

http://www.w3.org/2001/XMLSchema#string

Wei Wang

http://www.w3.org/2001/XMLSchema#string

Yuan Liu

http://www.w3.org/2001/XMLSchema#string

Yujie Su

http://www.w3.org/2001/XMLSchema#string

P2860

Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?

Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin

Cancer statistics, 2015

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Therapeutic nanoparticles for drug delivery in cancer

A tumorigenic subpopulation with stem cell properties in melanomas

Human mesenchymal stem cells modulate allogeneic immune cell responses

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells

Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure

P304

36910-36922

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C6RA00398B

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

drug delivery

nanoparticle